Peakdale appoints Killingworth to US Sales

Peakdale Molecular, from Chapel-en-le-Frith, UK, has appointed Glenn Killingworth as business development manager as part of the company's strategy to expand its US market share.

Glenn combines a wealth of experience of sales, marketing and business development in the US and Europe with a strong scientific background.

He joins Peakdale from his most recent position as business development manager at Chemical Synthesis Services (CSS), Northern Ireland, where he worked with both European and US-based companies and built a proven track record of commercial success. Previous to CSS, he was business development manager at Fisher Scientific UK, where he achieved the successful introduction of Fisher Scientifics' custom synthesis business in the US.

Kimberley Morrison, ceo of Peakdale Molecular, commented: 'Glenn's appointment reflects the importance of the US market for Peakdale and will strengthen our positioning. We are delighted that an individual of his calibre has joined the company. I anticipate that he will make a valuable contribution in our drive to expand our US market share. Importantly, our customers in the US will benefit from his experience in chemistry services and custom synthesis.'

'I am pleased to join Peakdale as part of the sales team at an exciting time in the Company's expansion', added Glenn. 'I particularly admire Peakdale's innovative approaches in custom synthesis and the development of the GPCR-targeted screening libraries and look forward to working with new customers and providing the company's unique chemistry know-how.'